Next Generation Food Allergy Drug Development
Evvnt Promotion / evvnt
Archiv
20.07.2021 - 22.07.2021 Online
Time: 11:00 to 17:00
Kongressthemen
In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/752787-3?pid=4832
Speakers: Melanie Dispenza, Assistant Professor, John Hopkins Medicine, Matthew Heath, Principal Scientist, Innovation and Product Development, Allergy Therapeutics, and more.
Brochure: https://go.evvnt.com/752787-3?pid=4832
Speakers: Melanie Dispenza, Assistant Professor, John Hopkins Medicine, Matthew Heath, Principal Scientist, Innovation and Product Development, Allergy Therapeutics, and more.
Anfragen und Anmeldung:
https://go.evvnt.com/752787-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 1499.00 to USD 2397.00
USD 1499.00 to USD 2397.00
Teilnehmer erwartet
1000 - 1000
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
